Journal Article Accepted manuscript SCCM/IDSA New Fever Guideline Correspondence Letter Get access Stanley C Deresinski, Stanley C Deresinski Division of Infectious Diseases, Stanford University, Redwood City, CA Corresponding author: Stanley Deresinski, MD, FIDSA, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, 300 Pasteur Dr Rm L134, Standford, CA 94305, United States, 650-723-6961 (office) or 650-725-8418 (fax), stan@polishmd.com Search for other works by this author on: Oxford Academic PubMed Google Scholar Naomi O'Grady Naomi O'Grady Critical Care Department, National Institutes of Health, Bethesda, MD Corresponding author: Naomi P. O'Grady, MD, FCCM, FIDSA, Internal Medicine Services, National Institutes of Health Clinical Center, Bethesda, MD, United States, nogrady@mail.cc.nih.gov Search for other works by this author on: Oxford Academic PubMed Google Scholar Clinical Infectious Diseases, ciae118, https://doi.org/10.1093/cid/ciae118 Published: 05 March 2024 Article history Received: 06 February 2024 Revision received: 07 February 2024 Accepted: 01 March 2024 Published: 05 March 2024
No takes yet. Share an insight, caveat, or question.
Deresinski et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: